Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort

doi:10.3748/wjg.v31.i33.109800

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1558)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

HTML

780

Figures (1-4)

347

Tables (1-2)

351

Sum=1486

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=63

Sep 7, 2025 (publication date) through Sep 4, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 7, 2025; 31(33): 109800
Published online Sep 7, 2025. doi: 10.3748/wjg.v31.i33.109800

Full Size Figure Download Figure

Figure 2 Cumulative probability of medication exposure. A: Cumulative exposure to inflammatory bowel disease (IBD) specific medications stratified by the time of diagnosis; B: Cumulative probability of biological therapy initiation in incident unclassified IBD patients - sub-analysis (2000-2018). IBD-U: Inflammatory bowel disease unclassified.

Citation: Balogh F, Gonczi L, Angyal D, Golovics PA, Pandur T, David G, Erdelyi Z, Szita I, Ilias A, Lakatos L, Lakatos PL. Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort. World J Gastroenterol 2025; 31(33): 109800
URL: https://www.wjgnet.com/1007-9327/full/v31/i33/109800.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i33.109800